BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33594155)

  • 21. Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis.
    Sossey-Alaoui K
    Semin Cell Dev Biol; 2013 Apr; 24(4):287-97. PubMed ID: 23116924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the WASF3 complex to suppress metastasis.
    Limaye AJ; Whittaker MK; Bendzunas GN; Cowell JK; Kennedy EJ
    Pharmacol Res; 2022 Aug; 182():106302. PubMed ID: 35691539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
    Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
    Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of WAVE3 sensitizes triple-negative breast cancers to chemotherapeutics by inhibiting the STAT-HIF-1α-mediated angiogenesis.
    Davuluri G; Schiemann WP; Plow EF; Sossey-Alaoui K
    JAKSTAT; 2014; 3(4):e1009276. PubMed ID: 26413422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WAVE3-NFκB interplay is essential for the survival and invasion of cancer cells.
    Davuluri G; Augoff K; Schiemann WP; Plow EF; Sossey-Alaoui K
    PLoS One; 2014; 9(10):e110627. PubMed ID: 25329315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WAVE3 functions as a negative regulator of LDOC1.
    Mizutani K; Koike D; Suetsugu S; Takenawa T
    J Biochem; 2005 Nov; 138(5):639-46. PubMed ID: 16272576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid WAVE dynamics in dendritic spines of cultured hippocampal neurons is mediated by actin polymerization.
    Pilpel Y; Segal M
    J Neurochem; 2005 Dec; 95(5):1401-10. PubMed ID: 16190876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression.
    Sossey-Alaoui K; Ranalli TA; Li X; Bakin AV; Cowell JK
    Exp Cell Res; 2005 Aug; 308(1):135-45. PubMed ID: 15907837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
    Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.
    Liao XH; Zhang Y; Dong WJ; Shao ZM; Li DQ
    Oncotarget; 2017 Nov; 8(58):97941-97954. PubMed ID: 29228664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WAVE3 upregulation in esophageal squamous cell carcinoma and its effect on the migration of human esophageal cancer cell lines in vitro.
    Li X; Geng J; Ren Z; Xiong C; Li Y; Liu H
    Mol Med Rep; 2020 Jul; 22(1):465-473. PubMed ID: 32377706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer.
    Shibuya N; Kakeji Y; Shimono Y
    Cancer Sci; 2020 Jun; 111(6):2093-2103. PubMed ID: 32307765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scar/WAVE3 contributes to motility and plasticity of lamellipodial dynamics but not invasion in three dimensions.
    Spence HJ; Timpson P; Tang HR; Insall RH; Machesky LM
    Biochem J; 2012 Nov; 448(1):35-42. PubMed ID: 22909346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
    Solomaha E; Szeto FL; Yousef MA; Palfrey HC
    J Biol Chem; 2005 Jun; 280(24):23147-56. PubMed ID: 15834155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance.
    Thiagarajan PS; Zheng Q; Bhagrath M; Mulkearns-Hubert EE; Myers MG; Lathia JD; Reizes O
    Endocr Relat Cancer; 2017 Aug; 24(8):415-426. PubMed ID: 28729467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.